Beginning on February 1, prescription co-payments will increase for some TRICARE beneficiaries. TRICARE network patient prescription copays will increase to $10 for a 30-day generic prescription, up from $8, and to $24 for a 30-day brand name prescription, up from $20. The increases were mandated under the fiscal 2016 National Defense Authorization Act, signed November 25, 2015, by President Obama.
NACDS has also consistently emphasized the important role of retail pharmacies in helping patients manage their health, as well as the cost-reducing benefits that the pharmacist-patient relationship can produce for military families and veterans…
NACDS has remained highly engaged in efforts to preserve pharmacy access and choice for TRICARE patients over the years. Advocating against increased copays, along with the National Community Pharmacy Association, NACDS has stated that increases place a great burden for TRICARE beneficiaries—especially retirees and families of active duty military—and also severely limit their ability to receive medications and services from their neighborhood pharmacies.
NACDS has also consistently emphasized the important role of retail pharmacies in helping patients manage their health, as well as the cost-reducing benefits that the pharmacist-patient relationship can produce for military families and veterans and the Department of Defense. These combined advocacy efforts prevented even higher copay increases.
More information about NACDS’ engagement on this issue can be accessed through the TRICARE tag on NACDS.org.
